Celularity Inc. (CELUW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Celularity Inc.

NASDAQ: CELUW · Real-Time Price · USD
0.05
0.01 (25.00%)
At close: Jun 09, 2025, 2:12 PM

Celularity Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
18.13M 9.3M 12.11M 14.68M 12.11M 3.79M 2.94M 3.94M 4.13M 4.13M 3.78M 5.93M 4.86M 10.62M 3.2M 2.66M
Cost of Revenue
1.25M 3.88M 2.12M 1.64M 9.61M 3.6M 1.04M 25.68M 5.25M 7.21M 3.18M 4.03M 4.66M 2.31M 1.44M 1.24M
Gross Profit
16.89M 5.41M 9.99M 13.04M 2.5M 184K 1.89M -21.74M -1.12M -3.08M 597K 1.91M 197K 8.31M 1.76M 1.42M
Operating Income
-9.28M -11.53M -10.18M -7.38M 13.31M -99.26M -42.48M -63.87M 17.48M -5.65M -40.87M -36.77M -14.95M 10.9M -60.61M -44.4M
Interest Income
77K 77K 67K 110K 115K 23K 66K 116K 210K 108K 41K 6K 8K 55K 129K 140K
Pretax Income
-13.29M -16.1M -6.49M -22.01M 9.56M -93.88M -47.95M -64.02M 24.45M 4.78M 47.84M -62.87M -4.02M 49.94M -64.48M -81.54M
Net Income
-26.78M -16.1M -6.49M -22.01M 9.55M -93.88M -47.95M -64.02M 24.43M 4.8M 47.83M -62.87M -4.04M 49.94M -64.48M -81.54M
Selling & General & Admin
16.06M 12.65M 15.91M 14.03M 13.07M 10.75M 12.83M 13.93M 19.08M 14.91M 15.57M 16.46M 13.21M 21.64M 28.86M 7.63M
Research & Development
3.83M 3.92M 3.8M 5.84M -272K 5.18M 8.6M 16.95M 10.99M 20.35M 25.35M 21.67M 24.69M 23.77M 22.91M 16.99M
Other Expenses
6.28M 375K 456K 546K -2.59M 1.14M -4.3M 541K -48.67M 987K 546K 541K 34.43M -109K -3.18M -27K
Operating Expenses
26.16M 16.94M 20.16M 20.42M -10.81M 16.73M 21.98M 31.43M -18.6M 35.81M 41.47M 38.67M 37.9M 45.96M 52.32M 25.16M
Interest Expense
-10.72M 1.75M 1.55M 1.15M 663K 971K 1.1M 277K n/a n/a n/a 26.1M 759K 843K 817K 752K
Selling & Marketing Expenses
n/a n/a n/a n/a 44K n/a n/a n/a 163K n/a n/a n/a 252K n/a n/a n/a
Cost & Expenses
27.41M 20.82M 22.29M 22.06M -1.2M 20.33M 23.02M 57.1M -13.36M 43.02M 44.65M 42.7M 42.55M 48.27M 53.76M 26.4M
Income Tax Expense
13.49M n/a n/a -13.49M 10K 2.11M -3.2M 424K 13K -17K 17K 26.1M 20K 734K 43.7K 43.7K
Shares Outstanding (Basic)
21.89M 21.98M 21.85M 21.44M 17.81M 18.78M 17.66M 15.54M n/a 14.27M 14.95M 13.04M 12.41M 12.48M 12.25M 12.25M
Shares Outstanding (Diluted)
21.89M 21.98M 21.85M 21.44M 17.81M 18.83M 17.66M 15.54M n/a 15.05M 15.13M 13.04M 12.41M 12.36M 12.25M 12.25M
EPS (Basic)
-0.58 -0.73 -0.3 -1.03 0.54 -5 -2.72 -4.12 n/a 0.30 3.41 -4.82 -0.33 4.69 -5.26 -6.66
EPS (Diluted)
-0.58 -0.73 -0.3 -1.03 0.54 -4.98 -2.72 -4.12 n/a 0.30 3.20 -4.82 -0.33 4.00 -5.26 -6.66
EBITDA
-30.05M -12.45M -2.94M -18.71M -8.55M -90.56M -44.52M -61.4M 26.89M -36.49M -38.55M -60.58M -655K 53.13M -48.63M -78.85M
EBIT
40.15M -14.35M -4.94M -20.86M -10.85M -92.91M -46.84M -63.74M 24.45M 4.78M -40.87M -62.87M -3.26M 50.78M -50.56M -80.79M
Depreciation & Amortization
-6.05M 1.89M 2M 2.16M 2.3M 2.34M 2.32M 2.34M 2.44M 2.39M 2.32M 2.28M 2.61M 2.35M 546K 1.94M